Abraxane (paclitaxel protein-bound particles for injectable suspension)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Abraxane (paclitaxel protein-bound particles for injectable suspension), covering 2018-03-22 to 2018-03-22. Get the full timeline:
Most recent: Clinical Trial Update: High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 2]